a pharmaceutical formulation comprising a solid matrix of one or more biodegradable polymers , the solid matrix including a pharmaceutically active substance or a pharmaceutically acceptable salt thereof distributed homogeneously or substantially homogeneously within the matrix ; wherein the pharmaceutically active substance is , for example , a gonadotropin releasing hormone , a gnrh agonist or a gnrh antagonist .